Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Leading Competitors
CHAPTER TWO: INTRODUCTION
- History of the Market
- Immune System
- Autoimmunity
- Genetic Factors
- Environmental Factors
- Gene Research
- Distribution
- Technology
- Demographics
CHAPTER THREE: MARKETS FOR RHEUMATOID ARTHRITIS
- Overview
- Description of Rheumatoid Arthritis
- Diagnosis
- Treatment Guidelines
- Economic Impact of Disease
- Trends in Insurance and Reimbursement
- Description of products
- Non-steroid Anti-inflammatory Drugs
- Biologic Treatments
- Disease Modifying Anti-rheumatic Drugs (DMARDs)
- Immunosuppressant and Other Biologic Drugs
- New Developments
- Market Overview
- Market by Product Type
- Market by Geographical Region
- Competitive Analysis
- Corporate Profiles
- Abbott Laboratories
- Amgen, Inc
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb
- Centocor, Inc.
- Genentech, Inc.
- Merck & Company, Inc.
- Novartis International AG
- Pfizer, Inc.
- Schering-Plough Corporation
- Wyeth
CHAPTER FOUR: MARKETS FOR LUPUS ERYTHEMATOSUS
- Overview
- Description of Lupus Erythematosus
- Diagnosis
- Risk Factors
- Treatment Guidelines
- Economic Impact of Disease
- Trends in Insurance and Reimbursement
- Description of products
- New Developments
- Market Overview
- Market by Product Type
- Market by Geographical Region
- Competitive Analysis
- Corporate Profiles
- Aspreva Pharmaceuticals Corporation
- Bristol-Myers Squibb
- Genelabs Technologies, Inc.
- Genentech, Inc.
- GlaxoSmithKline plc
- Human Genome Sciences
- La Jolla Pharmaceutical Company
- Roche
- UCB S.A.
CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST
- Overview
- Total Market Size and Forecast
- Markets by Segments
- Leading Competitors
CHAPTER SIX: LIST OF COMPANIES
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, 2004-2011
- Figure 1-1: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, 2004-2011
CHAPTER TWO: INTRODUCTION
- Table 2-1: World Population by Selected Geographical Region, 2006-2050
- Figure 2-1: World Population by Selected Geographical Region, 2006-2050
- Table 2-2: Estimated World Population by Age and Geographical Region, 2006
- Table 2-2: Estimated World Population by Age and Geographical Region, 2006
CHAPTER THREE: RHEUMATOID ARTHRITIS MARKETS
- Table 3-1: World Prevalence of Rheumatoid Arthritis by Region 25
- Figure 3-1: World Prevalence of Rheumatoid Arthritis, Percent by Region
- Table 3-2: Select Marketed Non-steroidal Anti-inflammatory Drugs
- Table 3-3: Selected Prescription Disease Modifying Anti-Rheumatic Drugs
- Table 3-4: Selected Prescription Immunosuppressant and Other Biologic Drugs
- Table 3-5: New Developments in Rheumatoid Arthritis
- Figure 3-2: Number of New Developments for Rheumatoid Arthritis by
Development Phase
- Table 3-6: The World Market for Prescription Rheumatoid Arthritis
Treatments, 2004-2011
- Figure 3-3: The World Market for Prescription Rheumatoid Arthritis
Treatments, 2004-2011
- Table 3-7: The World Market for Prescription Rheumatoid Arthritis
Treatments, by Product Type, 2004-2011
- Figure 3-4:The World Market for Prescription Rheumatoid Arthritis
Treatments, by Product Type, 2004-2011
- Figure 3-5: The World Market for Prescription Rheumatoid Arthritis
Treatments, by Product Type and Percent Distribution, 2004-2011
- Figure 3-6: The World Market for Prescription Rheumatoid Arthritis
Treatments, by Percent and Product Type, 2006
- Figure 3-7: The World Market for Prescription Rheumatoid Arthritis
Treatments, by Percent and Product Type, 2011
- Table 3-8: The World Market for Prescription Rheumatoid Arthritis, by
Geographic Region, 2006
- Figure 3-8: The World Market for Prescription Rheumatoid Arthritis, by
Geographic Region, 2006
- Table 3-9: Leading Suppliers' Shares of the World Market for Prescription
Rheumatoid Arthritis Treatments, 2006
- Figure 3-9: Leading Suppliers' Shares of the World Market for Prescription
Rheumatoid Arthritis Treatments, 2006
CHAPTER FOUR: LUPUS TREATMENT MARKETS
- Table 4-1: World Prevalence of Lupus by Region
- Figure 4-1: World Prevalence of Lupus, Percent by Region
- Table 4-2: Select Marketed Non-steroidal Anti-inflammatory Drugs
- Table 4-3: Selected Corticosteroids, Immunosuppressives and DMARDs
- Table 4-4: New Developments in Lupus Erythrematosus
- Figure 4-2: Number of New Developments for Lupus Erythrematosus by
Development Phase Table 4-5: The World Market for Prescription Lupus
Treatments, 2004-2011
- Figure 4-3: The World Market for Prescription Lupus Treatments, 2004-2011
- Table 4-6: The World Market for Prescription Lupus Treatments, by Product
Type, 2004-2011
- Figure 4-4: The World Market for Prescription Lupus Treatments, by Product
Type, 2004-2011
- Figure 4-5: The World Market for Prescription Lupus Treatments, by Product
Type and Percent Distribution, 2004-2011
- Figure 4-6: The World Market for Prescription Lupus Treatments, by Percent
and Product Type, 2006
- Figure 4-7: The World Market for Prescription Lupus Treatments, by Percent
and Product Type, 2011
- Table 4-7: The World Market for Prescription Lupus Treatments, by
Geographic Region, 2006
- Figure 4-8: The World Market for Prescription Lupus Treatments, by
Geographic Region, 2006
- Table 4-8: Estimated Leading Suppliers' Shares of the World Market for
Prescription Lupus Treatments, 2011
- Figure 4-9: Estimated Leading Suppliers' Shares of the World Market for
Prescription Lupus Treatments, 2011
CHAPTER FIVE: WORLD MARKET SUMMARY
- Table 5-1: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, 2004-2011
- Figure 5-1: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, 2004-2011
- Table 5-2: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, by Product Type, 2004-2011
- Figure 5-3: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, by Product Type, 2004-2011
- Figure 5-4: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, by Product Type and Percent Distribution, 2004-2011
- Figure 5-5: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, by Percent and Product Type, 2006
- Figure 5-6: The World Market for Prescription Rheumatoid Arthritis and
Lupus Treatments, by Percent and Product Type, 2011
|
Related Report
|
View Cart
